Combined PCI and minimally invasive heart valve surgery for high-risk patients

Ramanan Umakanthan1, Marzia Leacche, Michael R Petracek

  • 1Vanderbilt University Medical Center, Department of Cardiac Surgery, 1215 21st Avenue South, Nashville, TN 37232, USA.

Insights

Combined coronary artery and valvular heart disease poses significant health risks. A new hybrid suite allows for one-stage valve surgery and percutaneous coronary intervention (PCI), improving outcomes for select patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Combined coronary artery and valvular heart disease is a leading cause of death in adults.
  • Traditional treatment involves open-heart surgery (coronary artery bypass grafting and valve surgery) via median sternotomy and cardiopulmonary bypass.
  • Increasing patient complexity makes some individuals unsuitable for combined open-heart surgery.

Purpose of the Study:

  • To explore valve surgery combined with percutaneous coronary intervention (PCI) as an alternative for high-risk patients.
  • To address the logistical challenges of performing valve surgery and PCI in separate settings.
  • To introduce the concept and potential benefits of a hybrid procedural suite for simultaneous procedures.

Main Methods:

  • Development of a hybrid procedural suite combining cardiac surgical operating room and cardiac catheterization laboratory facilities.
  • Performance of valve surgery and PCI in a single hybrid suite in one setting.
  • Comparison of the one-stage approach with the conventional two-stage procedure.

Main Results:

  • The hybrid suite enables a "one-stage" or "one-stop" approach for valve surgery and PCI.
  • Procedures in the hybrid suite are performed minutes apart, unlike the hours or days separation in conventional methods.
  • Potential advantages include less invasive approaches, improved logistics, patient satisfaction, and outcomes for selected patients.

Conclusions:

  • Hybrid suites offer a novel solution for managing complex coronary artery and valvular heart disease.
  • This integrated approach facilitates the concomitant performance of valve surgery and PCI.
  • The one-stage hybrid procedure holds promise for improving patient care and outcomes in carefully selected individuals.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...